Expert Opinion on Pharmacotherapy

Socioeconomic inequalities of tuberculosis in India
pp. 1623-1628(6)
Authors: Muniyandi, M; Ramachandran, Rajeswari

Effects of sibutramine plus verapamil sustained release/trandolapril combination on blood pressure and metabolic variables in obese hypertensive patients
pp. 1629-1639(11)
Authors: Nakou, E; Filippatos, TD; Liberopoulos, EN; Tselepis, AD; Kiortsis, DN; Mikhailidis, DP; Elisaf, MS

Quality of life in hypertension management using olmesartan in primary care
pp. 1641-1653(13)
Authors: Schmidt, André C; Bramlage, Peter; Limberg, Roger; Kreutz, Reinhold

The effects of fexofenadine at steady-state on sleep architecture: a study using polysomnography in healthy Korean volunteers
pp. 1655-1665(11)
Authors: Lee, Ho-Won; Lee, Hae Won; Park, Dae Jin; Moon, Sung Ok; Ahn, Ju Hee; Kim, Mi Jin; Kim, Sung-Doo; Kim, Ji-Eun; Yoon, Young-Ran

Current treatment options and strategies for myelodysplastic syndromes
pp. 1667-1678(12)
Authors: Srinivasan, Sridhar; Schiffer, Charles A

Pharmacotherapy of essential thrombocythemia
pp. 1679-1685(7)
Authors: Gangat, Naseema; Tefferi, Ayalew

Phosphodiesterase-5 inhibitors in the treatment of lower urinary tract symptoms and benign prostatic hyperplasia
pp. 1687-1693(7)
Authors: Giannitsas, Konstantinos; Mitropoulos, Dionisios; Konstantinopoulos, Angelis; Athanasopoulos, Anastasios; Perimenis, Petros

What have we learned from the use of ciclosporin A in the treatment of nephrotic patients with idiopathic membranous nephropathy?
pp. 1695-1704(10)
Author: Goumenos, Dimitrios S

Sitagliptin in clinical practice: a new approach in the treatment of type 2 diabetes
pp. 1705-1720(16)
Authors: Mikhailidis, DP; Florentin, M; Liberopoulos, EN; MS, Elisaf

Management of narcolepsy
pp. 1721-1733(13)
Authors: Bhat, Abid; Solh, Ali A El

A pharmacoeconomic review of the management of respiratory tract infections with moxifloxacin
pp. 1735-1744(10)
Authors: Simoens, Steven; Decramer, Marc

Dalbavancin: a lipoglycopeptide antibacterial for Gram-positive infections
pp. 1745-1754(10)
Authors: Roecker, Andrew M; Pope, Scott D

Moxifloxacin: a respiratory fluoroquinolone
pp. 1755-1772(18)
Authors: Miravitlles, Marc; Anzueto, Antonio

Arsenic trioxide
pp. 1773-1785(13)
Author: Litzow, Mark R

Fesoterodine: a novel muscarinic receptor antagonist for the treatment of overactive bladder syndrome
pp. 1787-1796(10)
Author: Michel, Martin C

Long-term experience with hylan GF-20 in the treatment of knee osteoarthritis
pp. 1797-1804(8)
Authors: Conrozier, Thierry; Chevalier, Xavier

An alternative topical treatment of osteoarthritis of the knee with cutaneous diclofenac solution
pp. 1805-1816(12)
Authors: Özgüney, Işik